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ABSTRACT
The insulin receptor (IR) is an important hub in insulin
signaling and its activation is tightly regulated. Upon
insulin stimulation, IR is activated through autophos-
phorylation, and consequently phosphorylates several
insulin receptor substrate (IRS) proteins, including IRS1-
6, Shc and Gab1. Certain adipokines have also been
found to activate IR. On the contrary, PTP, Grb and SOCS
proteins, which are responsible for the negative regu-
lation of IR, are characterized as IR inhibitors. Addi-
tionally, many other proteins have been identiﬁed as IR
substrates and participate in the insulin signaling path-
way. To provide a more comprehensive understanding
of the signals mediated through IR, we reviewed the
upstream and downstream signal molecules of IR,
summarized the positive and negative modulators of IR,
and discussed the IR substrates and interacting adaptor
proteins. We propose that the molecular events associ-
ated with IR should be integrated to obtain a better
understanding of the insulin signaling pathway and
diabetes.
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INTRODUCTION
Input and output are two basic concepts in the ﬁeld of cellular
signal transduction (Waltermann and Klipp, 2011). In gen-
eral, the inputs of a signal transduction pathway are the
upstream stimulation and inhibition signals, whereas the
outputs are the downstream effects, such as the activation of
substrates and interactions with other proteins. The classical
insulin signaling pathway is initiated by the binding of insulin
to the insulin receptor (IR) and the subsequent activation of
insulin receptor substrate (IRS) proteins (Taniguchi et al.,
2006). For the hub protein IR, the input is insulin, and the
output is the phosphorylation of IRS proteins. However, the
scenario is not as simple as this one-way signal transduction
model. Recent progress in IR signaling indicated that insulin
is not the only ligand for IR, and the phosphorylation of IRS
proteins represents just one component of IR output. To
provide a more complete understanding of the signals
mediated through IR, we reviewed the inputs and outputs of
IR in this study. We will ﬁrst provide a brief description of the
classical stimulus and substrates of IR and then mainly focus
on the factors that positively and negatively regulate IR and
the various IR substrates and interacting proteins.
CLASSICAL INPUTS AND OUTPUTS OF IR
The binding of insulin to the α subunits of IR heterotetramer is
the main input into the insulin signaling pathway. The IR then
undergoes a conformational change in its intracellular β
subunits that exposes its ATP-binding domain, which enables
ATP binding and autophosphorylation. The output of IR
activation is the phosphorylation of a group of IRS proteins
(White and Kahn, 1994). IRS1 is the principal IRS protein and
is phosphorylated at multiple tyrosine sites upon insulin
stimulation (Sun et al., 1993). The tyrosine-phosphorylated
IRS1 sites function by docking with SH2 domain-containing
proteins and mediating signal transduction to various down-
stream factors. IRS2 is an alternative IR substrate that was
discovered in IRS1-deﬁcient mice (Patti et al., 1995). IRS1
and IRS2 are not functionally redundant, although they both
activate many similar downstream pathways (Waters and
Pessin, 1996; Hanke and Mann, 2009). IRS3 was ﬁrst cloned
in rat adipocytes and then in mouse. However, this homolog
does not appear to exist in human cells (Lavan et al., 1997b;
Sciacchitano and Taylor, 1997). IRS4 is the dominant IRS in
HEK293 cells (Lavan et al., 1997a). Although IRS1 and IRS2
are present in the HEK293 cell line, they are not activated
upon insulin stimulation (Fantin et al., 1998). These results
indicate that the output of IR is tissue-speciﬁc. IRS5 and
IRS6, also known as DOK4 and DOK5, are readily phos-
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phorylated in CHO-IR cells (Cai et al., 2003). IR-phosphory-
lated IRS5 binds to a number of SH2 domain-containing
proteins, that are distinct from those associated with IRS1.
However, IR-phosphorylated IRS6 does not bind to any SH2
domain-containing proteins, which indicates that it may
mediate a different branch of the insulin signaling pathway
(Cai et al., 2003). Shc interacts with and is phosphorylated by
IR. Phosphorylated Shc can dock with Grb2 and mediate
signal transduction through the Ras-MAPK signaling path-
way (Sasaoka and Kobayashi, 2000). Gab1 is another IRS
protein that is mainly involved in the PI3K-Akt pathway (Lehr
et al., 2000). The p85α subunit of PI3K can be directly
phosphorylated by IR after its docking to IRS1/2 (Hayashi
et al., 1993; Van Horn et al., 1994). Although the classical IR
inputs and outputs are simple and clear, they are only part of
the story (Fig. 1A).
In addition to the classical IRS proteins, many other pro-
teins have been shown to associate with IR and to play a
role in the insulin signaling pathway (Fig. 1B), which could be
classiﬁed into four different types: (1) Positive modulators of
IR (e.g., glypican-4 stimulates insulin function by binding to
IR); (2) Negative modulators of IR [e.g., protein tyrosine
phosphatases (PTPs), protein kinase C (PKC) isoforms,
growth factor receptor-bound (Grb) and suppressors of
cytokine signaling (SOCS) proteins]; (3) Alternative IR sub-
strates involved in various biological processes; and (4)
proteins that interact with IR, but are not its substrates. The
following section will focus on these four types of proteins in
an attempt to provide a complete description of the inputs
and outputs of IR. The related proteins and references are
summarized in Table 1.
POSITIVE MODULATORS OF IR
Insulin, IGF1 and IGF2 are traditional IR ligands. Some
adipokines have also been found to interact with the IR α
subunits and to enhance insulin sensitivity. Glypican-4,
which is released from adipose tissue into the circulation, is
a potential IR ligand. It binds to IR at regions different from
that of insulin (Ussar et al., 2012). The depletion of glypican-
4 reduces insulin signaling, whereas the overexpression of
wild-type glypican-4 enhances the insulin-mediated phos-
phorylation of ERK and AKT (Ussar et al., 2012), indicating
its potential role as a target for the treatment of insulin
resistance (Mitchell, 2012). Visfatin is related to the insulin
signaling pathway, but its role in the stimulation of IR remains
controversial (Adeghate, 2008).
NEGATIVE MODULATORS OF IR
The activity of IR is negatively regulated by several mecha-
nisms. PTPs can dephosphorylate IR at autophosphorylated
tyrosines and thus inactivate IR. Members of the PKC family
phosphorylate serinesnear autophosphorylated tyrosine sites
to disrupt the docking of SH2 domain-containing proteins.
Proteins in the Grb and SCOS families bind directly to IR and
block its interactionwith downstream factors. In addition, other
proteins, such as NEPP1 and AHSG, inhibit IR by interacting
with its extracellular domain. This indicates that a variety of
negative modulators of IR cooperate to inactivate IR. We here
summarized the important negative modulators of IR.
PTPs (PTP1B, PTP1C, TCPTP and PTPRF)
PTPs are encoded by approximately 100 genes in humans
(Alonso et al., 2004; Tonks, 2006). Classical PTPs dephos-
phorylate tyrosine phosphorylation to attenuate the function
of many receptor tyrosine kinases (Andersen et al., 2001;
Andersen et al., 2004). At least three PTPs proteins have
been found to be involved in the negative regulation of IR by
dephosphorylation. PTP1B is the best-known and most-
studied PTP and regulates IR activity via dephosphorylation.
It can be recruited to multiply tyrosine phosphorylation sites
on the IR through its SH2 domain upon insulin stimulation
and IR autophosphorylation (Seely et al., 1996). The tyro-
sines of PTP1B are then phosphorylated by IR, and this step
greatly increases its dephosphorylation activity (Dadke et al.,
2001). Phosphorylated PTP1B can dephosphorylate IR and
inhibit its kinase activity (Salmeen et al., 2000). This typical
negative feedback is widely present in biological processes.
In addition, phosphorylated PTP1B can dephosphorylate
itself to balance its catalytic activity. PTP1B has been rec-
ognized as a potential target for the enhancement of insulin
sensitization through a series of functional studies (Delibe-
govic et al., 2007; Picardi et al., 2008; Delibegovic et al.,
2009; Ma et al., 2011). Similar to PTP1B, TCPTP uses
autophosphorylated IR as a direct substrate both in vivo and
Figure 1. The diagram illustrating the inputs and outputs of
insulin receptor. (A) Classical IR inputs and outputs. (B) Sum-
mary of proteins associating with IR which include positive
modulator (purple), negative modulator (red), alternative sub-
strates (green) and interactors (blue). Arrow: stimulation; Line:
interaction; Arrow with ﬂathead: inhibition.
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in vitro (Lammers et al., 1993; Galic et al., 2003). Although
both PTP1B and TCPTP inhibit the activity of IR by
dephosphorylation, the catalytic tyrosine sites might be
different. PTP1B prefers to tandem phosphorylate tyrosine,
whereas TCPTP mainly catalyzes a single phosphorylated
tyrosine (Galic et al., 2005). PTPRF, which is a
Table 1. Proteins associated with the inputs and outputs of insulin receptor
Protein Function References
Positive modulators
Glypican-4 Binds IR α subunits. Facilitates insulin-induced formational change of IR Ussar et al. 2012
Negative modulators
PTP1B Major PTP involved in insulin signaling. Dephosphorylates IR tyrosine Salmeen et al. 2000
TCPTP Cooperates with PTP1B. Dephosphorylate IR tyrosine Galic et al. 2003
PTPRF Dephosphorylates IR tyrosine Hashimoto et al. 1992
PKCδ Predominant in muscle. Phosphorylates IR serine Braiman et al. 2001
PKCε Predominant in liver. Phosphorylates IR serine Samuel et al. 2007
Grb7 Binds IR in vitro and in vivo Kasus-Jacobi et al. 2000
Grb10 Binds IR. Blocks IRS1/2 Wick et al. 2003
Grb14 Binds IR. Blocks PTP1B Nouaille et al. 2006
SOCS1 Binds IR. Interrupts IRS2 Ueki et al. 2004
SOCS3 Binds IR. Interrupts IRS1/2, STAT5B Emanuelli et al. 2000
SOCS6 Binds IR. Interrupts IRS1 Mooney et al. 2001
ENPP1 Binds IR α subunits. Inhibits insulin-induced conformational change of IR Maddux and Goldﬁne, 2000
AHSG Binds IR β subunits extracellular region Mathews et al. 2000
Alternative substrates
ADRB2 Transmembrane protein. Phosphorylated by IR in vitro and in vivo Baltensperger et al. 1996
Calmodulin Calcium-dependent protein. Phosphorylated by IR in vitro and in vivo Sacks et al. 1992
CEACAM1 Transmembrane protein. Phosphorylated by IR in vitro and in vivo Poy et al. 2002a
Dok1 GAP-associated protein. Phosphorylated by IR in vitro and in vivo Wick et al. 2001
FABP4 Fatty acid-binding protein. Phosphorylated by IR in vitro Buelt et al. 1991
FAK1 Integrin signaling pathway. Phosphorylated by IR in vitro Baron et al. 1998
FRS2 FGFR substrate. Phosphorylated by IR in vitro Delahaye et al. 2000
PTP1C Protein tyrosine phosphatase. Phosphorylated by IR in vitro and in vivo Uchida et al. 1994
SH2B1 Interacts with IR and phosphorylated upon insulin stimulation in vivo Kotani et al. 1998
SH2B2 Interacts with IR and phosphorylated upon insulin stimulation in vivo Moodie et al. 1999
STAT5B Transcriptional factor. Phosphorylated by IR in vitro and in vivo Chen et al. 1997
SYNCRIP RNA-binding protein. Phosphorylated by IR in vitro Hresko and Mueckler, 2002
Sam68 RNA-binding protein. Phosphorylated by IR in vitro and in vivo Sanchez-Margalet and Najib, 1999
Vav3 Interacts with and phosphorylated by IR activation in vivo Zeng et al. 2000
Proteins interacting with IR, but are not its substrates (Interactors)
ARF Interacts with activated IR. PLD regulation Shome et al. 1997
hMAD2 Interacts with inactivated IR O’Neill et al. 1997
JAK1 Interacts with activated IR. Enhances IRS1 activation Gual et al. 1998
PLCγ1 Interacts with activated IR. Enhances MAPK activation Kwon et al. 2003
PTP1D Interacts with activated IR. Enhances IRS1 activation Kharitonenkov et al. 1995
RACK1 Interacts with activated IR. Facilitates STAT3 activation Zhang et al. 2006
SORBS1 Interacts with inactivated IR Lin et al. 2001
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transmembrane PTP, also interacts with and dephosphoryl-
ates IR in vitro and in vivo (Hashimoto et al., 1992; Ahmad
and Goldstein, 1997). It can be deduced that PTP1B,
TCPTP and PTPRF crosstalk with each other to negatively
regulate IR. In summary, three PTPs can act as negative
inputs to IR via tyrosine dephosphorylation under conditions
of insulin stimulation.
PKCs (PKCδ and PKCε)
The PKC family consists of three distinct groups, namely, the
classical, novel and atypical groups. In contrast to PTPs,
which dephosphorylate proteins, PKCs function by phos-
phorylating serines or threonines. Several members in the
PKC family have been shown to be involved in negatively
regulating IR activity. In vitro-puriﬁed PKC can also phos-
phorylate IR and lower its tyrosine kinase activity (Bollag
et al., 1986). In vivo studies using insulin-resistant human
skeletal muscle suggest that PKCδ is recruited to IR and
reduces its activity via serine phosphorylation (Itani et al.,
2000; Braiman et al., 2001; Rosenzweig et al., 2004). In
insulin-resistant liver, PKCε is the predominant activated
PKC. PKCε inhibits insulin signaling by binding to IR and
reducing its tyrosine kinase activity in hepatic steatosis
(Samuel et al., 2007; Jornayvaz et al., 2011; Jornayvaz and
Shulman, 2012). These studies indicate that PKC isoforms
regulate IR activity in a tissue-speciﬁc manner. In addition,
PKC can inhibit the insulin signaling pathway by phosphor-
ylating other proteins in the insulin signaling pathway. For
example, PKCθ prefers IRS1 for phosphorylation (Grifﬁn
et al., 1999; Yu et al., 2002; Li et al., 2004). In summary, at
least two PKCs act as negative inputs to IR via serine
phosphorylation.
Grb proteins (Grb10, Grb14 and Grb7)
Unlike PTPs and PKC, which inhibit IR by covalently mod-
iﬁcation, Grb proteins reduce the activity of IR through direct
interaction. The autophosphorylated tyrosine sites on IR not
only dock IRS but also SH2 domain-containing proteins,
which are not phosphorylated or activated by IR. These
types of proteins compete with IRS for IR binding and then
serve to inhibit IR activity. Grb10 was ﬁrst found to be a high
afﬁnity interacting protein with IR in vitro (Liu and Roth,
1995). Further studies demonstrated that the Grb10 SH-2
domain and IR carboxyl catalytic active loop are required for
this interaction (Hansen et al., 1996). Grb10 binds to the
same domain as IRS1 on IR. This binding blocks the IR-
mediated phosphorylation of IRS1 and disrupts the IRS1-
PI3K signaling pathway (Wick et al., 2003). The biological
role of Grb10 in promoting insulin signaling has been proven
using a mouse model (Smith et al., 2007; Wang et al., 2007).
Similar to Grb10, Grb14 binds to IR and blocks its auto-
phosphorylation in a site-speciﬁc manner (Nouaille et al.,
2006). The phenotypes of mice deﬁcient in Grb14 and Grb10
differ, which indicates the non-redundant functions of these
two proteins (Holt and Siddle, 2005). Grb7 is an additional
Grb protein that participates in IR regulation. It binds to
activated IR both in vitro and in vivo and may function in the
same manner as Grb14 and Grb10 (Kasus-Jacobi et al.,
2000). In summary, three Grb proteins can inhibit IR activity
by directly blocking downstream signaling.
SOCS proteins (SOCS1, SOCS3 and SOCS6)
Initially identiﬁed as cytokine signaling inhibitors, SOCS pro-
teins participate in various signal transduction pathways,
including the insulin signaling pathway. Similar to Grb proteins,
SOCS proteins directly interact with IR and block downstream
signal transduction. For example, SOCS3 attenuates the IR-
STAT5Bsignal branchbycompetingwithSTAT5B for binding to
IR at phosphorylated tyrosine 960 (Emanuelli et al., 2000).
SOCS3 also interrupts the IRS1 and IRS2 signal branch with
the same mechanism (Ueki et al., 2004). Moreover, SOCS3
overexpression in cultured cells inhibits IR autophosphoryla-
tion. This mechanism is most likely mediated by crosstalk
between IRregulators (Sennetal., 2003). Inaddition,SOCS3 is
induced by STAT5B upon insulin stimulation (Emanuelli et al.,
2000; Sadowski et al., 2001). This constitutes another negative
feedback loop in the insulin signaling pathway. SOCS1binds to
IR on sites different from that of SOCS3, although they are both
IR inhibitors (Mooney et al., 2001; Le et al., 2002; Ueki et al.,
2004). SOCS6binds toboth IRand IRS4,which indicates that it
inhibits the insulin signaling pathway by targeting multiple
proteins (Mooney et al., 2001; Krebs et al., 2002). SOCS pro-
teins can be induced by inﬂammation, which partially explains
the role of inﬂammation in insulin resistance (Tanti et al., 2012;
Suchy et al., 2013). We concluded that at least three SOCS
proteins provide negative inputs to IR.
ENPP1
ENPP1 (ectonucleotide pyrophosphatase/phosphodiester-
ase family member 1) is a transmembrane protein with
alkaline phosphodiesterase and nucleotide pyrophospha-
tase activity. However, its inhibition of IR autophosphoryla-
tion is independent of its enzymatic activity (Grupe et al.,
1995). In contrast to Grb and SOCS proteins, which inhibit IR
activity by interacting with its β subunits, ENPP1 directly
binds to the IR α subunits (Maddux and Goldﬁne, 2000).
ENPP1 does not appear to affect insulin binding, but inhibits
the insulin-induced conformational change of the IR α sub-
units (Maddux and Goldﬁne, 2000). The ENPP1 K173Q
polymorphism (previously described as K121Q) has been
associated with insulin resistance (Costanzo et al., 2001;
McAteer et al., 2008; Moore et al., 2009) because the K173Q
polymorphism tightly binds to IR and effectively inhibits IR.
There are seven members in the ENPP family (Masse et al.,
2010). Given the similarity between ENPP1 and the other
ENPPs, particularly ENPP2 (Kato et al., 2012), it is possible
that these other ENPPs may participate in the insulin sig-
naling pathway. Furthermore, the up-regulation of ENPP2
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has been associated with insulin resistance in a diabetic
mouse model (Boucher et al., 2005). Thus, it can be con-
cluded that ENPP1 inhibits IR by blocking the conformational
change of IR upon insulin binding.
AHSG
AHSG (alpha-2-Heremans-Schmid glycoprotein) inhibits the
autophosphorylation of IR by interacting with the extracellular
region of its β subunits (Auberger et al., 1989; Srinivas et al.,
1993; Mathews et al., 2000). The mechanism of this inhibition
may be similar to that of ENPP1. AHSG is secreted by the liver
and is released into the circulation. The blood levels of AHSG
have been correlated with insulin resistance (Kalabay et al.,
2002; Goustin and Abou-Samra, 2011). Thus, it is becoming
clear that AHSG is another negative input of IR.
ALTERNATIVE SUBSTRATES OF IR
IR substrates are not restricted to the classical ones men-
tioned above. A variety of proteins have been found to be
phosphorylated by activated IR. We categorized these pro-
teins into different IR outputs and review their roles in the
insulin signaling pathway in this section.
ADRB2
ADRB2 (beta-2-adrenergic receptor) is a member of the
G-protein coupled receptor superfamily and can be phos-
phorylated by IR both in vivo and in vitro (Baltensperger
et al., 1996). The phosphorylated tyrosine site on ADRB2
can recruit Grb2 and other proteins to promote the internal-
ization of ADRB2 (Karoor et al., 1998). This indicates that the
insulin signaling pathway may crosstalk with the GPCR
(G-protein coupled receptor) signaling pathway.
Calmodulin
Calmodulin is a multifunctional calcium-dependent messen-
ger protein that can be phosphorylated by different types of
kinases, including IR (Laurino et al., 1988; Sacks and
McDonald, 1988;Wong et al., 1988; Sacks et al., 1989; Sacks
and McDonald, 1989; Sacks et al., 1992). The phosphoryla-
tion of calmodulin hasaneffect on its intrinsic enzymeproperty
and on its downstream interacting proteins (Benaim and Vil-
lalobo, 2002). IR phosphorylates calmodulin at two major
tyrosine sites, which attenuates its biological activity (Saville
and Houslay, 1994; Williams et al., 1994; Sacks et al., 1995;
Joyal et al., 1996). However, the precise role of this phos-
phorylation related to insulin signaling is unclear. Calmodulin
may serve as a node for the crosstalk between the insulin
signaling pathway and other signaling pathways.
CEACAM1
CEACAM1 (carcinoembryonic antigen-related cell adhesion
molecule 1) is another transmembrane substrate of IR. IR
phosphorylates CEACAM1 on its intracellular domain to
initiate IR internalization (Formisano et al., 1995). CEA-
CAM1-mediated IR internalization and degradation is
important for insulin clearance in the liver (Poy et al., 2002b).
The tyrosine-phosphorylated sites on CEACAM1 also com-
pete with IR for Shc binding, thus attenuating IR signaling
transduction to the MARK pathway (Poy et al., 2002a).
Dok1
Dok1 (docking protein 1) is phosphorylated by IR at speciﬁc
tyrosine sites. Phosphorylated Dok1 enhances its binding to
GAP, which is an inhibitor of RAS (Wick et al., 2001). Thus,
RAS is dually regulated by the insulin signaling pathway: it is
activated by Grb2-SOS and inactivated by Dok1-GAP. Dok2
and Dok3 do not appear to be related to the insulin signaling
pathway, but these proteins interact with GAP and may play
an important role in other pathways (Di Cristofano et al.,
1998; Lemay et al., 2000).
FABP4
FABP4 (fatty acid-binding protein 4) is mainly expressed in
adipocytes, which can be phosphorylated by the puriﬁed IR β
subunits in vitro (Buelt et al., 1991). In addition, results
obtained from FABP4-deﬁcient mice indicate that this protein
may serve as a bridge linking obesity to insulin resistance
(Hotamisligil et al., 1996). However, it remains unclear
whether FABP4 is a substrate of IR in vivo and whether it
participates in the insulin signaling pathway.
FAK1
FAK1 (focal adhesion kinase 1) is a cytosolic tyrosine kinase
involved in integrin signaling. IR promotes FAK1 phosphor-
ylation in suspended cells (Baron et al., 1998). In contrast, IR
stimulates the dephosphorylation of FAK1 in attached cells
(Pillay et al., 1995). The biological role of IR-phosphorylated
FAK1 remains to be elucidated. The dual role of IR in FAK1
regulation may be related to the integrin-mediated signaling
pathway.
FRS2
FRS2 (ﬁbroblast growth factor receptor substrate 2) was
originally found to be an adapter protein that links activated
FGR receptors to the downstream signaling pathway (Xu
et al., 1998). It has also been revealed to be a direct sub-
strate of IR in vitro and becomes tyrosine phosphorylated
upon insulin stimulation in vivo (Delahaye et al., 2000).
PTP1C
PTP1C is able to bind to autophosphorylated IR and is
phosphorylated by activated IR on its tyrosine residues
(Uchida et al., 1994). In addition, the phosphatase activity of
phosphorylated PTP1C increases. However, there is no
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evidence demonstrating that it can directly dephosphorylate
IR, although PTP1C-deﬁcient mice exhibit increased glucose
tolerance and insulin sensitivity (Dubois et al., 2006).
SH2B1/2
SH2B1 and 2 are SH2 domain-containing proteins that can
be tyrosine phosphorylated upon insulin stimulation
(Yokouchi et al., 1997; Kotani et al., 1998; Wang and Riedel,
1998; Moodie et al., 1999). The insulin-induced phosphory-
lation of SH2B1/2 is potentially mediated by IR. Similar to
Grb2 and Shc, phosphorylated SH2B1 and 2 may serve as a
docking site for downstream factors. For example, phos-
phorylated SH2B2 can dock c-Cbl to IR and promote IR
ubiquitination and internalization (Ahmed et al., 2000). In
addition, SH2B 1 and 2 serve as an adaptor and substrates
for other tyrosine kinase receptors, such as receptors of
PDGF (platelet-derived growth factor), NGF (nerve growth
factor), and FGF (ﬁbroblast growth factor) (Rui and Carter-
Su, 1998; Kong et al., 2002; Wang et al., 2004).
STAT5B
STAT5B (signal transducer and activator of transcription 5B)
has been demonstrated to be a direct substrate for IR both
in vitro and in vivo (Chen et al., 1997; Sawka-Verhelle et al.,
1997; Storz et al., 1999; Sawka-Verhelle et al., 2000).
Phosphorylated STAT5B acts as a transcription factor and
activates a series of target genes, including glucokinase and
SOCS proteins (Sawka-Verhelle et al., 2000; Sadowski
et al., 2001). Insulin-induced gene expression events may be
partially mediated by STAT5B.
SYNCRIP and Sam68
IR substrates are not restricted to cytoplasmic enzymes and
transcriptional factors. IR also phosphorylates RNA-binding
proteins. For instance, the RNA-binding protein SYNCRIP
(synaptotagmin-binding cytoplasmic RNA-interacting protein)
is phosphorylated by IR in vitro (Hresko and Mueckler, 2000,
2002). Moreover, this phosphorylation can be disrupted by
RNA binding. The RNA-binding protein Sam68, which can be
induced by insulin, is phosphorylated by IR both in vitro and
in vivo (Sanchez-Margalet and Najib, 1999; Sanchez-Marga-
let et al., 2003). Tyrosine-phosphorylated Sam68 (the 68 kDa
Src substrate associated during mitosis) can dock with p85
PI3K and GAP proteins (Sanchez-Margalet and Najib, 2001).
TheRNA-binding activity of Sam68 is also affected by tyrosine
phosphorylation (Wang et al., 1995), indicating a role of the
insulin signaling pathway in RNA metabolism.
Vav3
Vav3 is a member of the guanine nucleotide exchange factor
family, which activates multiple pathways. Vav3 interacts
with and is phosphorylated by IR when overexpressed in
293T cells (Zeng et al., 2000). IR-phosphorylated Vav3
promotes Rac-1 activation and actin cytoskeletal rear-
rangement and modulates the formation of cell membrane
rufﬂes (Zeng et al., 2000).
PROTEINS INTERACT WITH IR BUT ARE NOT ITS
SUBSTRATES
IR does not always provide an output signal via catalysis.
Under certain conditions, signals from IR are transmitted by
changes in its interaction status with its binding partners. For
example, inactivated IR interacts with hMAD2 (human
homolog of yeast MAD2) with high afﬁnity. This interaction
decreases upon IR activation (O’Neill et al., 1997). Similarly,
SORBS1 (sorbin and SH3 domain-containing 1) dissociates
from IR and binds to c-Abl upon insulin stimulation (Lin et al.,
2001). Although the biological function of these types of
proteins in the insulin signaling pathway remains unclear,
they enable signal transduction through IR.
In cells overexpressing IR, JAK1 (Janus kinase1) has been
observed to interact with IR (Gual et al., 1998). In addition, the
phosphorylation of both proteins is necessary for their inter-
action. The binding of JAK1 to IR may facilitate its catalytic
activity to IRS1. RACK1 (receptor for activated C kinase 1)
interacts with both IR and STAT3 in vitro. In addition, RACK1
mediates IR-induced STAT3 activation in vivo (Zhang et al.,
2006). These results indicate that IR transmits signals to
STAT3 via RACK1. ARF (ADP-ribosylation factor) has been
coimmunoprecipitated with activated IR and serves as an
adaptor to IR-mediated PLD regulation (Shome et al., 1997).
In addition, PTP1D (protein tyrosine phosphatase 1D), which
is a member of the PTP family, can bind to both IR and IRS1
and enhance the docking of IRS1 to IR (Kharitonenkov et al.,
1995). PLCγ1 (phospholipase C gamma 1) can interact with
activated IR in a SH2 domain-independent manner, which
may be mediated by conformational changes of IR (Kwon
et al., 2003). The binding to PLCγ1 leads to phosphorylation,
which plays a role in signal transduction to MAPK. Thus, the
IR-mediated signals can be transmitted by interacting proteins
independent of its catalytic activity.
CONCLUSIONS
After four decades of extensive investigation, a growing body
of knowledge on IR has been accumulated. In this review,
we summarized the signals input to or output from IR (Fig. 1).
Although each signal branch through IR is clear and
understandable, the integration of all of the signal branches
to obtain a full understanding of insulin signaling remains
challenging. To fully understand the IR signaling cascades, it
is not sufﬁcient to study IR-interacting proteins or signal
branches one-by-one; all related proteins and pathways
must be integrated. The typical cellular response to insulin
stimulation is the phosphorylation of classical IRS and IRS-
mediated macromolecular complex docking. However, we
should consider other independently reported docking
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proteins, such as Dok1, SH2B1 and SH2B2 to the macro-
molecular docking process. In parallel with the docking event
is the direct activation of a group of proteins, including cal-
modulin, STAT5B and SYNCRIP. We should also integrate
the negative regulation mechanisms with the activation
event triggered by IR. The represented members of negative
regulators are PTPs, PKCs, Grb and SOCS proteins. In
addition, insulin may be dissociated or internalized and
degraded via a CEACAM-mediated mechanism. And there
should be other IR related proteins and events which remain
to be elucidated. Only if the input and output signals are
integrated into one story, we may eventually obtain a full
understanding of IR signaling.
ACKNOWLEDGMENTS
This work was supported by grants from the National Basic
Research Program of China (2010CB833701) and the National
Natural Science Foundation of China (Grant No. 31070736). The
authors are indebted to Profs. Fuyu Yang and Pingsheng Liu (IBP,
CAS) for helpful comments and suggestions.
ABBREVIATIONS
CEACAM1, carcinoembryonic antigen-related cell adhesion
molecule 1; Dok1, docking protein 1; FABP4, fatty acid-binding
protein 4; FRS2, ﬁbroblast growth factor receptor substrate 2; Grb,
growth factor receptor-bound; IR, insulin receptor; IRS, insulin
receptor substrate; JAK1, Janus kinase 1; PKC, protein kinase C;
PTP, protein tyrosine phosphatase; RACK1, receptor for activated C
kinase 1; Sam68, the 68 kDa Src substrate associated during
mitosis; SOCS, suppressors of cytokine signaling; SORBS1, sorbin
and SH3 domain-containing 1; STAT5B, signal transducer and
activator of transcription 5B; SYNCRIP, synaptotagmin-binding
cytoplasmic RNA-interacting protein.
COMPLIANCE WITH ETHICS GUIDELINES
Yipeng Du and Taotao Wei declare that they have no conﬂict of
interest.
This article does not contain any studies with human or animal
subjects performed by the any of the authors.
OPEN ACCESS
This article is distributed under the terms of the Creative Commons
Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and
the source are credited.
REFERENCES
Adeghate E (2008) Visfatin: structure, function and relation to
diabetes mellitus and other dysfunctions. Curr Med Chem
15:1851–1862
Ahmad F, Goldstein BJ (1997) Functional association between the
insulin receptor and the transmembrane protein-tyrosine phos-
phatase LAR in intact cells. J Biol Chem 272:448–457
Ahmed Z, Smith BJ, Pillay TS (2000) The APS adapter protein
couples the insulin receptor to the phosphorylation of c-Cbl and
facilitates ligand-stimulated ubiquitination of the insulin receptor.
FEBS Lett 475:31–34
Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A,
Godzik A, Hunter T, Dixon J, Mustelin T (2004) Protein tyrosine
phosphatases in the human genome. Cell 117:699–711
Andersen JN, Mortensen OH, Peters GH, Drake PG, Iversen LF,
Olsen OH, Jansen PG, Andersen HS, Tonks NK, Moller NP
(2001) Structural and evolutionary relationships among
protein tyrosine phosphatase domains. Mol Cell Biol 21:7117–
7136
Andersen JN, Jansen PG, Echwald SM, Mortensen OH, Fukada T,
Del Vecchio R, Tonks NK, Moller NP (2004) A genomic
perspective on protein tyrosine phosphatases: gene structure,
pseudogenes, and genetic disease linkage. FASEB J 18:8–30
Auberger P, Falquerho L, Contreres JO, Pages G, Le Cam G, Rossi
B, Le Cam A (1989) Characterization of a natural inhibitor of the
insulin receptor tyrosine kinase: cDNA cloning, puriﬁcation, and
anti-mitogenic activity. Cell 58:631–640
Baltensperger K, Karoor V, Paul H, Ruoho A, Czech MP, Malbon CC
(1996) The beta-adrenergic receptor is a substrate for the insulin
receptor tyrosine kinase. J Biol Chem 271:1061–1064
Baron V, Calleja V, Ferrari P, Alengrin F, Van Obberghen E (1998)
p125Fak focal adhesion kinase is a substrate for the insulin and
insulin-like growth factor-I tyrosine kinase receptors. J Biol Chem
273:7162–7168
Benaim G, Villalobo A (2002) Phosphorylation of calmodulin.
Functional implications. Eur J Biochem 269:3619–3631
Bollag GE, Roth RA, Beaudoin J, Mochly-Rosen D, Koshland DE Jr
(1986) Protein kinase C directly phosphorylates the insulin
receptor in vitro and reduces its protein-tyrosine kinase activity.
Proc Natl Acad Sci USA 83:5822–5824
Boucher J, Quilliot D, Praderes JP, Simon MF, Gres S, Guigne C,
Prevot D, Ferry G, Boutin JA, Carpene C et al (2005) Potential
involvement of adipocyte insulin resistance in obesity-associated
up-regulation of adipocyte lysophospholipase D/autotaxin
expression. Diabetologia 48:569–577
Braiman L, Alt A, Kuroki T, Ohba M, Bak A, Tennenbaum T,
Sampson SR (2001) Insulin induces speciﬁc interaction between
insulin receptor and protein kinase C delta in primary cultured
skeletal muscle. Mol Endocrinol 15:565–574
Buelt MK, Shekels LL, Jarvis BW, Bernlohr DA (1991) In vitro
phosphorylation of the adipocyte lipid-binding protein (p15) by the
insulin receptor. Effects of fatty acid on receptor kinase and
substrate phosphorylation. J Biol Chem 266:12266–12271
Cai D, Dhe-Paganon S, Melendez PA, Lee J, Shoelson SE (2003)
Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/
DOK5. J Biol Chem 278:25323–25330
Chen J, Sadowski HB, Kohanski RA, Wang LH (1997) Stat5 is a
physiological substrate of the insulin receptor. Proc Natl Acad Sci
USA 94:2295–2300
Costanzo BV, Trischitta V, Di Paola R, Spampinato D, Pizzuti A,
Vigneri R, Frittitta L (2001) The Q allele variant (GLN121) of
membrane glycoprotein PC-1 interacts with the insulin receptor
and inhibits insulin signaling more effectively than the common K
allele variant (LYS121). Diabetes 50:831–836
Regulation of insulin receptor REVIEW









Dadke S, Kusari A, Kusari J (2001) Phosphorylation and activation
of protein tyrosine phosphatase (PTP) 1B by insulin receptor. Mol
Cell Biochem 221:147–154
Delahaye L, Rocchi S, Van Obberghen E (2000) Potential involve-
ment of FRS2 in insulin signaling. Endocrinology 141:621–628
Delibegovic M, Bence KK, Mody N, Hong EG, Ko HJ, Kim JK, Kahn
BB, Neel BG (2007) Improved glucose homeostasis in mice with
muscle-speciﬁc deletion of protein-tyrosine phosphatase 1B. Mol
Cell Biol 27:7727–7734
Delibegovic M, Zimmer D, Kauffman C, Rak K, Hong EG, Cho YR,
Kim JK, Kahn BB, Neel BG, Bence KK (2009) Liver-speciﬁc
deletion of protein-tyrosine phosphatase 1B (PTP1B) improves
metabolic syndrome and attenuates diet-induced endoplasmic
reticulum stress. Diabetes 58:590–599
Di Cristofano A, Carpino N, Dunant N, Friedland G, Kobayashi R,
Strife A, Wisniewski D, Clarkson B, Pandolﬁ PP, Resh MD (1998)
Molecular cloning and characterization of p56dok-2 deﬁnes a new
family of RasGAP-binding proteins. J Biol Chem 273:4827–4830
Dubois MJ, Bergeron S, Kim HJ, Dombrowski L, Perreault M,
Fournes B, Faure R, Olivier M, Beauchemin N, Shulman GI et al
(2006) The SHP-1 protein tyrosine phosphatase negatively
modulates glucose homeostasis. Nat Med 12:549–556
Emanuelli B, Peraldi P, Filloux C, Sawka-Verhelle D, Hilton D, Van
Obberghen E (2000) SOCS-3 is an insulin-induced negative
regulator of insulin signaling. J Biol Chem 275:15985–15991
Fantin VR, Sparling JD, Slot JW, Keller SR, Lienhard GE, Lavan BE
(1998) Characterization of insulin receptor substrate 4 in human
embryonic kidney 293 cells. J Biol Chem 273:10726–10732
Formisano P, Najjar SM, Gross CN, Philippe N, Oriente F, Kern-Buell
CL, Accili D, Gorden P (1995) Receptor-mediated internalization
of insulin. Potential role of pp120/HA4, a substrate of the insulin
receptor kinase. J Biol Chem 270:24073–24077
Galic S, Klingler-Hoffmann M, Fodero-Tavoletti MT, Puryer MA,
Meng TC, Tonks NK, Tiganis T (2003) Regulation of insulin
receptor signaling by the protein tyrosine phosphatase TCPTP.
Mol Cell Biol 23:2096–2108
Galic S, Hauser C, Kahn BB, Haj FG, Neel BG, Tonks NK, Tiganis T
(2005) Coordinated regulation of insulin signaling by the protein
tyrosine phosphatasesPTP1BandTCPTP.MolCell Biol 25:819–829
Goustin AS, Abou-Samra AB (2011) The “thrifty” gene encoding
Ahsg/Fetuin-A meets the insulin receptor: Insights into the
mechanism of insulin resistance. Cell Signal 23:980–990
Grifﬁn ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D,
Goodyear LJ, Kraegen EW, White MF, Shulman GI (1999) Free
fatty acid-induced insulin resistance is associated with activation
of protein kinase C theta and alterations in the insulin signaling
cascade. Diabetes 48:1270–1274
Grupe A, Alleman J, Goldﬁne ID, Sadick M, Stewart TA (1995)
Inhibition of insulin receptor phosphorylation by PC-1 is not
mediated by the hydrolysis of adenosine triphosphate or the
generation of adenosine. J Biol Chem 270:22085–22088
Gual P, Baron V, Lequoy V, Van Obberghen E (1998) Interaction of
Janus kinases JAK-1 and JAK-2 with the insulin receptor and the
insulin-like growth factor-1 receptor. Endocrinology 139:884–893
Hanke S, Mann M (2009) The phosphotyrosine interactome of the
insulin receptor family and its substrates IRS-1 and IRS-2. Mol
Cell Proteomics 8:519–534
Hansen H, Svensson U, Zhu J, Laviola L, Giorgino F, Wolf G, Smith
RJ, Riedel H (1996) Interaction between the Grb10 SH2 domain
and the insulin receptor carboxyl terminus. J Biol Chem
271:8882–8886
Hashimoto N, Feener EP, Zhang WR, Goldstein BJ (1992) Insulin
receptor protein-tyrosine phosphatases. Leukocyte common
antigen-related phosphatase rapidly deactivates the insulin
receptor kinase by preferential dephosphorylation of the receptor
regulatory domain. J Biol Chem 267:13811–13814
Hayashi H, Nishioka Y, Kamohara S, Kanai F, Ishii K, Fukui Y,
Shibasaki F, Takenawa T, Kido H, Katsunuma N et al (1993) The
alpha-type 85-kDa subunit of phosphatidylinositol 3-kinase is
phosphorylated at tyrosines 368, 580, and 607 by the insulin
receptor. J Biol Chem 268:7107–7117
Holt LJ, Siddle K (2005) Grb10 and Grb14: enigmatic regulators of
insulin action–and more? Biochem J 388:393–406
Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE,
Spiegelman BM (1996) Uncoupling of obesity from insulin
resistance through a targeted mutation in aP2, the adipocyte
fatty acid binding protein. Science 274:1377–1379
Hresko RC, Mueckler M (2000) A novel 68-kDa adipocyte protein
phosphorylated on tyrosine in response to insulin and osmotic
shock. J Biol Chem 275:18114–18120
Hresko RC, Mueckler M (2002) Identiﬁcation of pp68 as the tyrosine-
phosphorylated form of SYNCRIP/NSAP1. A cytoplasmic RNA-
binding protein. J Biol Chem 277:25233–25238
Itani SI, Zhou Q, Pories WJ, MacDonald KG, Dohm GL (2000)
Involvement of protein kinase C in human skeletal muscle insulin
resistance and obesity. Diabetes 49:1353–1358
Jornayvaz FR, Shulman GI (2012) Diacylglycerol activation of
protein kinase Cepsilon and hepatic insulin resistance. Cell
Metab 15:574–584
Jornayvaz FR, Birkenfeld AL, Jurczak MJ, Kanda S, Guigni BA, Jiang
DC, Zhang D, Lee HY, Samuel VT, Shulman GI (2011) Hepatic
insulin resistance inmicewith hepatic overexpression of diacylglyc-
erol acyltransferase 2. Proc Natl Acad Sci USA 108:5748–5752
Joyal JL, Crimmins DL, Thoma RS, Sacks DB (1996) Identiﬁcation
of insulin-stimulated phosphorylation sites on calmodulin. Bio-
chemistry 35:6267–6275
Kalabay L, Cseh K, Pajor A, Baranyi E, Csakany GM, Melczer Z,
Speer G, Kovacs M, Siller G, Karadi I et al (2002) Correlation of
maternal serum fetuin/alpha2-HS-glycoprotein concentration with
maternal insulin resistance and anthropometric parameters of
neonates in normal pregnancy and gestational diabetes. Eur J
Endocrinol 147:243–248
Karoor V, Wang L, Wang HY, Malbon CC (1998) Insulin stimulates
sequestration of beta-adrenergic receptors and enhanced asso-
ciation of beta-adrenergic receptors with Grb2 via tyrosine 350.
J Biol Chem 273:33035–33041
Kasus-Jacobi A, Bereziat V, Perdereau D, Girard J, Burnol AF
(2000) Evidence for an interaction between the insulin receptor
and Grb7. A role for two of its binding domains, PIR and SH2.
Oncogene 19:2052–2059
Kato K, Nishimasu H, Okudaira S, Mihara E, Ishitani R, Takagi J,
Aoki J, Nureki O (2012) Crystal structure of Enpp1, an extracel-
lular glycoprotein involved in bone mineralization and insulin
signaling. Proc Natl Acad Sci USA 109:16876–16881
REVIEW Yipeng Du and Taotao Wei









Kharitonenkov A, Schnekenburger J, Chen Z, Knyazev P, Ali S,
Zwick E, White M, Ullrich A (1995) Adapter function of protein-
tyrosine phosphatase 1D in insulin receptor/insulin receptor
substrate-1 interaction. J Biol Chem 270:29189–29193
Kong M, Wang CS, Donoghue DJ (2002) Interaction of ﬁbroblast
growth factor receptor 3 and the adapter protein SH2-B. A role in
STAT5 activation. J Biol Chem 277:15962–15970
Kotani K, Wilden P, Pillay TS (1998) SH2-Balpha is an insulin-
receptor adapter protein and substrate that interacts with the
activation loop of the insulin-receptor kinase. Biochem J 335(Pt
1):103–109
Krebs DL, Uren RT, Metcalf D, Rakar S, Zhang JG, Starr R, De
Souza DP, Hanzinikolas K, Eyles J, Connolly LM et al (2002)
SOCS-6 binds to insulin receptor substrate 4, and mice lacking
the SOCS-6 gene exhibit mild growth retardation. Mol Cell Biol
22:4567–4578
Kwon YK, Jang HJ, Kole S, He HJ, Bernier M (2003) Role of the
pleckstrin homology domain of PLCgamma1 in its interaction with
the insulin receptor. J Cell Biol 163:375–384
Lammers R, Bossenmaier B, Cool DE, Tonks NK, Schlessinger J,
FischerEH,UllrichA (1993)Differential activitiesof protein tyrosine
phosphatases in intact cells. J Biol Chem 268:22456–22462
Laurino JP, Colca JR, Pearson JD, DeWald DB, McDonald JM
(1988) The in vitro phosphorylation of calmodulin by the insulin
receptor tyrosine kinase. Arch Biochem Biophys 265:8–21
Lavan BE, Fantin VR, Chang ET, Lane WS, Keller SR, Lienhard GE
(1997a) A novel 160-kDa phosphotyrosine protein in insulin-
treated embryonic kidney cells is a new member of the insulin
receptor substrate family. J Biol Chem 272:21403–21407
Lavan BE, Lane WS, Lienhard GE (1997b) The 60-kDa phosphoty-
rosine protein in insulin-treated adipocytes is a newmember of the
insulin receptor substrate family. J Biol Chem 272:11439–11443
Le MN, Kohanski RA, Wang LH, Sadowski HB (2002) Dual
mechanism of signal transducer and activator of transcription 5
activation by the insulin receptor. Mol Endocrinol 16:2764–2779
Lehr S, Kotzka J, Herkner A, Sikmann A, Meyer HE, Krone W,
Muller-Wieland D (2000) Identiﬁcation of major tyrosine phos-
phorylation sites in the human insulin receptor substrate Gab-1
by insulin receptor kinase in vitro. Biochemistry 39:10898–10907
Lemay S, Davidson D, Latour S, Veillette A (2000) Dok-3, a novel
adapter molecule involved in the negative regulation of immuno-
receptor signaling. Mol Cell Biol 20:2743–2754
Li Y, Soos TJ, Li X, Wu J, Degennaro M, Sun X, Littman DR,
Birnbaum MJ, Polakiewicz RD (2004) Protein kinase C Theta
inhibits insulin signaling by phosphorylating IRS1 at Ser(1101).
J Biol Chem 279:45304–45307
Lin WH, Huang CJ, Liu MW, Chang HM, Chen YJ, Tai TY, Chuang
LM (2001) Cloning, mapping, and characterization of the human
sorbin and SH3 domain containing 1 (SORBS1) gene: a protein
associated with c-Abl during insulin signaling in the hepatoma cell
line Hep3B. Genomics 74:12–20
Liu F, Roth RA (1995) Grb-IR: a SH2-domain-containing protein that
binds to the insulin receptor and inhibits its function. Proc Natl
Acad Sci USA 92:10287–10291
Ma YM, Tao RY, Liu Q, Li J, Tian JY, Zhang XL, Xiao ZY, Ye F (2011)
PTP1B inhibitor improves both insulin resistance and lipid
abnormalities in vivo and in vitro. Mol Cell Biochem 357:65–72
Maddux BA, Goldﬁne ID (2000) Membrane glycoprotein PC-1
inhibition of insulin receptor function occurs via direct interaction
with the receptor alpha-subunit. Diabetes 49:13–19
Masse K, Bhamra S, Allsop G, Dale N, Jones EA (2010) Ectopho-
sphodiesterase/nucleotide phosphohydrolase (Enpp) nucleotida-
ses: cloning, conservation and developmental restriction. Int J
Dev Biol 54:181–193
Mathews ST, Chellam N, Srinivas PR, Cintron VJ, Leon MA, Goustin
AS, Grunberger G (2000) Alpha2-HSG, a speciﬁc inhibitor of
insulin receptor autophosphorylation, interacts with the insulin
receptor. Mol Cell Endocrinol 164:87–98
McAteer JB, Prudente S, Bacci S, Lyon HN, Hirschhorn JN,
Trischitta V, Florez JC, Consortium E (2008) The ENPP1
K121Q polymorphism is associated with type 2 diabetes in
European populations: evidence from an updated meta-analysis
in 42, 042 subjects. Diabetes 57:1125–1130
Mitchell F (2012) Obesity: glypican-4: role in insulin signalling. Nat
Rev Endocrinol 8:505
Moodie SA, Alleman-Sposeto J, Gustafson TA (1999) Identiﬁcation
of the APS protein as a novel insulin receptor substrate. J Biol
Chem 274:11186–11193
Mooney RA, Senn J, Cameron S, Inamdar N, Boivin LM, Shang Y,
Furlanetto RW (2001) Suppressors of cytokine signaling-1 and -6
associate with and inhibit the insulin receptor. A potential
mechanism for cytokine-mediated insulin resistance. J Biol Chem
276:25889–25893
Moore AF, Jablonski KA, Mason CC, McAteer JB, Arakaki RF,
Goldstein BJ, Kahn SE, Kitabchi AE, Hanson RL, Knowler WC
et al (2009) The association of ENPP1 K121Q with diabetes
incidence is abolished by lifestyle modiﬁcation in the diabetes
prevention program. J Clin Endocrinol Metab 94:449–455
Nouaille S, Blanquart C, Zilberfarb V, Boute N, Perdereau D, Roix J,
Burnol AF, Issad T (2006) Interaction with Grb14 results in site-
speciﬁc regulation of tyrosine phosphorylation of the insulin
receptor. EMBO Rep 7:512–518
O’Neill TJ, Zhu Y, Gustafson TA (1997) Interaction of MAD2 with the
carboxyl terminus of the insulin receptor but not with the IGFIR.
Evidence for release from the insulin receptor after activation.
J Biol Chem 272:10035–10040
Patti ME, Sun XJ, Bruening JC, Araki E, Lipes MA, White MF, Kahn
CR (1995) 4PS/insulin receptor substrate (IRS)-2 is the alterna-
tive substrate of the insulin receptor in IRS-1-deﬁcient mice.
J Biol Chem 270:24670–24673
Picardi PK, Calegari VC, Prada PO, Moraes JC, Araujo E,
Marcondes MC, Ueno M, Carvalheira JB, Velloso LA, Saad MJ
(2008) Reduction of hypothalamic protein tyrosine phosphatase
improves insulin and leptin resistance in diet-induced obese rats.
Endocrinology 149:3870–3880
Pillay TS, Sasaoka T, Olefsky JM (1995) Insulin stimulates the
tyrosine dephosphorylation of pp125 focal adhesion kinase.
J Biol Chem 270:991–994
Poy MN, Ruch RJ, Fernstrom MA, Okabayashi Y, Najjar SM (2002a)
Shc and CEACAM1 interact to regulate the mitogenic action of
insulin. J Biol Chem 277:1076–1084
Poy MN, Yang Y, Rezaei K, Fernstrom MA, Lee AD, Kido Y, Erickson
SK, Najjar SM (2002b) CEACAM1 regulates insulin clearance in
liver. Nat Genet 30:270–276
Regulation of insulin receptor REVIEW









Rosenzweig T, Aga-Mizrachi S, Bak A, Sampson SR (2004) Src
tyrosine kinase regulates insulin-induced activation of protein
kinaseC (PKC) delta in skeletal muscle. Cell Signal 16:1299–1308
Rui L, Carter-Su C (1998) Platelet-derived growth factor (PDGF)
stimulates the association of SH2-Bbeta with PDGF receptor and
phosphorylation of SH2-Bbeta. J Biol Chem 273:21239–21245
Sacks DB, McDonald JM (1988) Insulin-stimulated phosphorylation
of calmodulin by rat liver insulin receptor preparations. J Biol
Chem 263:2377–2383
Sacks DB, McDonald JM (1989) Calmodulin as substrate for insulin-
receptor kinase. Phosphorylation by receptors from rat skeletal
muscle. Diabetes 38:84–90
Sacks DB, Fujita-Yamaguchi Y, Gale RD, McDonald JM (1989)
Tyrosine-speciﬁc phosphorylation of calmodulin by the insulin
receptor kinase puriﬁed from human placenta. Biochem J
263:803–812
Sacks DB, Davis HW, Crimmins DL, McDonald JM (1992) Insulin-
stimulated phosphorylation of calmodulin. Biochem J 286(Pt
1):211–216
Sacks DB, Mazus B, Joyal JL (1995) The activity of calmodulin is
altered by phosphorylation: modulation of calmodulin function by
the site of phosphate incorporation. Biochem J 312(Pt 1):197–
204
Sadowski CL, Choi TS, Le M, Wheeler TT, Wang LH, Sadowski HB
(2001) Insulin Induction of SOCS-2 and SOCS-3 mRNA expres-
sion in C2C12 Skeletal Muscle Cells Is Mediated by Stat5*. J Biol
Chem 276:20703–20710
Salmeen A, Andersen JN, Myers MP, Tonks NK, Barford D (2000)
Molecular basis for the dephosphorylation of the activation
segment of the insulin receptor by protein tyrosine phosphatase
1B. Mol Cell 6:1401–1412
Samuel VT, Liu ZX, Wang A, Beddow SA, Geisler JG, Kahn M,
Zhang XM, Monia BP, Bhanot S, Shulman GI (2007) Inhibition of
protein kinase Cepsilon prevents hepatic insulin resistance in
nonalcoholic fatty liver disease. J Clin Invest 117:739–745
Sanchez-Margalet V, Najib S (1999) p68 Sam is a substrate of the
insulin receptor and associates with the SH2 domains of p85
PI3K. FEBS Lett 455:307–310
Sanchez-Margalet V, Najib S (2001) Sam68 is a docking protein
linking GAP and PI3K in insulin receptor signaling. Mol Cell
Endocrinol 183:113–121
Sanchez-Margalet V, Gonzalez-Yanes C, Najib S, Fernandez-
Santos JM, Martin-Lacave I (2003) The expression of Sam68, a
protein involved in insulin signal transduction, is enhanced by
insulin stimulation. Cell Mol Life Sci 60:751–758
Sasaoka T, Kobayashi M (2000) The functional signiﬁcance of Shc in
insulin signaling as a substrate of the insulin receptor. Endocr J
47:373–381
Saville MK, Houslay MD (1994) Phosphorylation of calmodulin on
Tyr99 selectively attenuates the action of calmodulin antagonists
on type-I cyclic nucleotide phosphodiesterase activity. Biochem J
299(Pt 3):863–868
Sawka-Verhelle D, Filloux C, Tartare-Deckert S, Mothe I, Van
Obberghen E (1997) Identiﬁcation of Stat 5B as a substrate of the
insulin receptor. Eur J Biochem 250:411–417
Sawka-Verhelle D, Tartare-Deckert S, Decaux JF, Girard J, Van
Obberghen E (2000) Stat 5B, activated by insulin in a Jak-
independent fashion, plays a role in glucokinase gene transcrip-
tion. Endocrinology 141:1977–1988
Sciacchitano S, Taylor SI (1997) Cloning, tissue expression, and
chromosomal localization of the mouse IRS-3 gene. Endocrinol-
ogy 138:4931–4940
Seely BL, Staubs PA, Reichart DR, Berhanu P, Milarski KL, Saltiel
AR, Kusari J, Olefsky JM (1996) Protein tyrosine phosphatase 1B
interacts with the activated insulin receptor. Diabetes 45:1379–
1385
Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Koniaris LG, Furlanetto
RW, Mooney RA (2003) Suppressor of cytokine signaling-3
(SOCS-3), a potential mediator of interleukin-6-dependent insulin
resistance in hepatocytes. J Biol Chem 278:13740–13746
ShomeK,VasudevanC,RomeroG(1997)ARFproteinsmediate insulin-
dependent activation of phospholipase D. Curr Biol 7:387–396
Smith FM, Holt LJ, Garﬁeld AS, Charalambous M, Koumanov F,
Perry M, Bazzani R, Sheardown SA, Hegarty BD, Lyons RJ et al
(2007) Mice with a disruption of the imprinted Grb10 gene exhibit
altered body composition, glucose homeostasis, and insulin
signaling during postnatal life. Mol Cell Biol 27:5871–5886
Srinivas PR, Wagner AS, Reddy LV, Deutsch DD, Leon MA, Goustin
AS, Grunberger G (1993) Serum alpha 2-HS-glycoprotein is an
inhibitor of the human insulin receptor at the tyrosine kinase level.
Mol Endocrinol 7:1445–1455
Storz P, Doppler H, Pﬁzenmaier K, Muller G (1999) Insulin
selectively activates STAT5b, but not STAT5a, via a JAK2-
independent signalling pathway in Kym-1 rhabdomyosarcoma
cells. FEBS Lett 464:159–163
Suchy D, Labuzek K, Machnik G, Kozlowski M, Okopien B (2013)
SOCS and diabetes–ups and downs of a turbulent relationship.
Cell Biochem Funct 31:181–195
Sun XJ, Crimmins DL, Myers MG Jr, Miralpeix M, White MF (1993)
Pleiotropic insulin signals are engaged by multisite phosphory-
lation of IRS-1. Mol Cell Biol 13:7418–7428
Taniguchi CM, Emanuelli B, Kahn CR (2006) Critical nodes in
signalling pathways: insights into insulin action. Nat Rev Mol Cell
Biol 7:85–96
Tanti JF, Ceppo F, Jager J, Berthou F (2012) Implication of
inﬂammatory signaling pathways in obesity-induced insulin
resistance. Front Endocrinol (Lausanne) 3:181
Tonks NK (2006) Protein tyrosine phosphatases: from genes, to
function, to disease. Nat Rev Mol Cell Biol 7:833–846
Uchida T, Matozaki T, Noguchi T, Yamao T, Horita K, Suzuki T,
Fujioka Y, Sakamoto C, Kasuga M (1994) Insulin stimulates the
phosphorylation of Tyr538 and the catalytic activity of PTP1C, a
protein tyrosine phosphatase with Src homology-2 domains.
J Biol Chem 269:12220–12228
Ueki K, Kondo T, Kahn CR (2004) Suppressor of cytokine signaling 1
(SOCS-1) and SOCS-3 cause insulin resistance through inhibi-
tion of tyrosine phosphorylation of insulin receptor substrate
proteins by discrete mechanisms. Mol Cell Biol 24:5434–5446
Ussar S, Bezy O, Bluher M, Kahn CR (2012) Glypican-4 enhances
insulin signaling via interaction with the insulin receptor and
serves as a novel adipokine. Diabetes 61:2289–2298
Van Horn DJ, Myers MG Jr, Backer JM (1994) Direct activation of the
phosphatidylinositol 3’-kinase by the insulin receptor. J Biol Chem
269:29–32
REVIEW Yipeng Du and Taotao Wei









Waltermann C, Klipp E (2011) Information theory based approaches
to cellular signaling. Biochim Biophys Acta 1810:924–932
Wang J, Riedel H (1998) Insulin-like growth factor-I receptor and
insulin receptor association with a Src homology-2 domain-
containing putative adapter. J Biol Chem 273:3136–3139
Wang LL, Richard S, Shaw AS (1995) P62 association with RNA is
regulated by tyrosine phosphorylation. J Biol Chem 270:2010–2013
Wang X, Chen L, Maures TJ, Herrington J, Carter-Su C (2004) SH2-
B is a positive regulator of nerve growth factor-mediated
activation of the Akt/Forkhead pathway in PC12 cells. J Biol
Chem 279:133–141
Wang L, Balas B, Christ-Roberts CY, Kim RY, Ramos FJ, Kikani CK,
Li C, Deng C, Reyna S, Musi N et al (2007) Peripheral disruption
of the Grb10 gene enhances insulin signaling and sensitivity
in vivo. Mol Cell Biol 27:6497–6505
Waters SB, Pessin JE (1996) Insulin receptor substrate 1 and 2 (IRS1
and IRS2): what a tangled web we weave. Trends Cell Biol 6:1–4
White MF, Kahn CR (1994) The insulin signaling system. J Biol
Chem 269:1–4
Wick MJ, Dong LQ, Hu D, Langlais P, Liu F (2001) Insulin receptor-
mediated p62dok tyrosine phosphorylation at residues 362 and
398 plays distinct roles for binding GTPase-activating protein and
Nck and is essential for inhibiting insulin-stimulated activation of
Ras and Akt. J Biol Chem 276:42843–42850
Wick KR, Werner ED, Langlais P, Ramos FJ, Dong LQ, Shoelson
SE, Liu F (2003) Grb10 inhibits insulin-stimulated insulin receptor
substrate (IRS)-phosphatidylinositol 3-kinase/Akt signaling path-
way by disrupting the association of IRS-1/IRS-2 with the insulin
receptor. J Biol Chem 278:8460–8467
Williams JP, Jo H, Sacks DB, Crimmins DL, Thoma RS, Hunnicutt
RE, Radding W, Sharma RK, McDonald JM (1994) Tyrosine-
phosphorylated calmodulin has reduced biological activity. Arch
Biochem Biophys 315:119–126
Wong EC, Sacks DB, Laurino JP, McDonald JM (1988) Character-
istics of calmodulin phosphorylation by the insulin receptor
kinase. Endocrinology 123:1830–1836
XuH, LeeKW,GoldfarbM (1998)Novel recognitionmotif on ﬁbroblast
growth factor receptormediates direct associationandactivationof
SNTadapter proteins. J Biol Chem 273:17987–17990
Yokouchi M, Suzuki R, MasuharaM, Komiya S, Inoue A, Yoshimura A
(1997) Cloning and characterization of APS, an adaptor molecule
containing PH and SH2 domains that is tyrosine phosphorylated
upon B-cell receptor stimulation. Oncogene 15:7–15
Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R,
Kim JK, Cushman SW, Cooney GJ et al (2002) Mechanism by
which fatty acids inhibit insulin activation of insulin receptor
substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase
activity in muscle. J Biol Chem 277:50230–50236
Zeng L, Sachdev P, Yan L, Chan JL, Trenkle T, McClelland M, Welsh
J, Wang LH (2000) Vav3 mediates receptor protein tyrosine
kinase signaling, regulates GTPase activity, modulates cell
morphology, and induces cell transformation. Mol Cell Biol
20:9212–9224
Zhang W, Zong CS, Hermanto U, Lopez-Bergami P, Ronai Z, Wang
LH (2006) RACK1 recruits STAT3 speciﬁcally to insulin and
insulin-like growth factor 1 receptors for activation, which is
important for regulating anchorage-independent growth. Mol Cell
Biol 26:413–424
Regulation of insulin receptor REVIEW
© The Author(s) 2014. This article is published with open access at Springerlink.com and journal.hep.com.cn 213
P
ro
te
in
&
C
e
ll
